Advertisement

Management of the N0 Neck in Oral Cancer

  • Richard W. Nason
  • K. Alok Pathak
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

The status of the regional lymph nodes is considered to be one of the major prognostic factors of oral cancer. Cure rates drop by ~50 % when the regional lymph nodes are involved. The N0 neck, by definition, means that involvement of the cervical lymph nodes is not evident on clinical assessment, including physical examination and imaging studies. Occult metastases are generally identified at the time of pathological examination of the neck dissection specimen. The long-standing debate concerning the management of the clinically negative neck centres on two basic and interrelated themes. The first is not a necessity in the timing of lymphadenectomy—the question of elective treatment of the neck versus a ‘wait and watch’ approach. The second is the anatomical extent of treatment, if occult metastatic disease is elected to be treated.

Keywords

Sentinel Lymph Node Sentinel Lymph Node Biopsy Oral Cancer Neck Dissection Radical Neck Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pitman K, Johnson J, Myers E. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1997;123:917–22.CrossRefPubMedGoogle Scholar
  2. 2.
    Byers RM, El-Naggar AK, Lee YY, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998;20:138–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990;160:405–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Yuen AP, Wei WI, Wong YM, et al. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Vandenbrouck C, Sancho-Garnier H, Chassagne D, et al. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Results of a randomized clinical trial. Cancer 1980;46:386–90.CrossRefPubMedGoogle Scholar
  6. 6.
    Fakih AR, Rao RS, Borges AM, et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989;158:309–13.CrossRefPubMedGoogle Scholar
  7. 7.
    Gourin CG, Conger BT, Porubsky ES, et al. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. The Laryngoscope 2008;118:1191–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Woolgar JA, Rogers SN, Lowe D, et al. Cervical lymph node metastasis in oral cancer: The importance of even microscopic extracapsular spread. Oral Oncology 2003;39:130–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Andersen PE, Cambronero E, Shaha AR, et al. The extent of neck disease after regional failure during observation of the No neck. Am J Surg 1996;172:689–91.CrossRefPubMedGoogle Scholar
  10. 10.
    Jess RH, Barkley HT Jr, Lindberg RD, et al. Cancer of the oral cavity. Is elective neck dissection beneficial? Am J Surg 1970;120:505–8.CrossRefGoogle Scholar
  11. 11.
    Northrop M, Fletcher GH, Jesse RH, et al. Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral. Cancer 1972;29:23–30.CrossRefPubMedGoogle Scholar
  12. 12.
    van den Brekel MW, Catelijns JA, Snow GB. Imaging of cervical lymphadenopathy. Neuroimaging Clin N Am 1996;6:417–34.PubMedGoogle Scholar
  13. 13.
    O’Brien CJ, Lauer CS, Fredricks S, et al. Tumor thickness influences prognosis of T1 and T2 oral cavity cancer—but what thickness? Head Neck 2003;25:937–45.CrossRefPubMedGoogle Scholar
  14. 14.
    Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis 1998;4:70–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Nason RW, Castillo NB, Sako K, et al. Cervical node metastases in early squamous cell carcinoma of the floor of the mouth: Predictive value of multiple histopathological parameters. World J Surg 1990;14:606–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Cheng A, Schmidt BL. Management of the No neck in oral squamous cell carcinoma. Oral Maxillofacial Surg Clin N Am 2008;20:477–97.CrossRefGoogle Scholar
  17. 17.
    Kligerman J, Lima RA, Soares JR, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168: 391–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Lydiatt DD, Robbins KT, Byers RM, et al. Treatment of stage I and II oral tongue cancer. Head Neck 1993;15:308–12.CrossRefPubMedGoogle Scholar
  19. 19.
    Haddadin KJ, Soutar DS, Oliver RJ, et al. Improved survival for patients with clinically T1/T2, No tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517–25.CrossRefPubMedGoogle Scholar
  20. 20.
    Dias FL, Kligerman J, Matos De Sa G, et al. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125:23–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Capote A, Escorial V, Munoz-Guerra MF, et al. Elective Neck Dissection in early-stage oral squamous cell carcinoma—does it influence recurrence and survival? Head Neck 2007;29:3–11.CrossRefPubMedGoogle Scholar
  22. 22.
    Huang SF, Kang CJ, Lin CY, et al. Neck treatment of patient with early stage oral tongue cancer. Cancer 2008;112:1066–75.CrossRefPubMedGoogle Scholar
  23. 23.
    Nason RW, Sako K, Beecroft WA, et al. Surgical management of squamous cell carcinoma of the floor of the mouth. Am J Surg 1989;158:292–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Nason R, El-Sayed A, Cooke A, et al. Management of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Current Oncology 1996;3:92–7.Google Scholar
  25. 25.
    Ferlito A, Rinaldo A, Suarez O. Often-forgotten father of functional neck dissection (in the non-Spanish-speaking literature). Laryngoscope 2004;114:1177–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Bocca E, Pignataro O, Oldini C, et al. Functional neck dissection: An evaluation and review of 843 cases. Laryngoscope 1984;94:942–5.PubMedGoogle Scholar
  27. 27.
    Medina JE, Byers RM. Supraomohyoid neck dissection: Rationale, indications, and surgical technique. Head Neck 1989;11:111–22.CrossRefPubMedGoogle Scholar
  28. 28.
    Lindberg R. Distribution of lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Shah JP, Medina JE, Shaha AR, et al. Cervical lymph node metastasis. Curr Probl Surg 1993;30:1–335.CrossRefPubMedGoogle Scholar
  30. 30.
    Byers RM. Modified neck dissection. A study of 957 cases from 1970 to 1980. Am J Surg 1985;150:414–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Kowalski LP, Magrin J, Waksman G, et al. Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch Otolaryngol Head Neck Surg 1993;119:958–63.CrossRefPubMedGoogle Scholar
  32. 32.
    McGuirt WF Jr, Johnson JT, Myers EN, et al. Floor of mouth carcinoma. The management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1995;121:278–82.CrossRefPubMedGoogle Scholar
  33. 33.
    Spiro RH, Morgan GJ, Strong EW, et al. Supraomohyoid neck dissection. Am J Surg 1996;172:650–3.CrossRefPubMedGoogle Scholar
  34. 34.
    Fletcher GH, Jess RH Jr. Proceedings: Irradiation management of squamous cell carcinomas of the oral cavity. Proc Natl Cancer Conf 1972;7:137–42.PubMedGoogle Scholar
  35. 35.
    Leemans CR, Snow GB. Is selective neck dissection really as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts? Arch Otolaryngol Head Neck Surg 1998;124:1042–4.CrossRefPubMedGoogle Scholar
  36. 36.
    Brazilian Head and Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998;176:422–7.CrossRefGoogle Scholar
  37. 37.
    Spiro RH, Gallo O, Shah JP. Selective jugular node dissection in patients with squamous carcinoma of the larynx or pharynx. Am J Surg 1993;166:399–402.CrossRefPubMedGoogle Scholar
  38. 38.
    Byers RM, Weber RS, Andrews T, et al. Frequency and therapeutic implications of ‘skip metastases’ in the neck from squamous carcinoma of the oral tongue. Head Neck 1997;19:14–19.CrossRefPubMedGoogle Scholar
  39. 39.
    Robbins KT, Shaha AR, Medina JE, et al., Committee for Neck Dissection Classification, American Head and Neck Society. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008;134:536–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Krag DN. Minimal access surgery for staging regional lymph nodes: The sentinel-node concept. Curr Probl Surg 1998;35:951–1016.CrossRefPubMedGoogle Scholar
  41. 41.
    van den Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996;106:987–91.CrossRefPubMedGoogle Scholar
  42. 42.
    Ross GL, Soutar DS, MacDonald DG, et al. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 2004;11:213–18.CrossRefPubMedGoogle Scholar
  43. 43.
    Stoeckli SJ, Alkureishi LW, Ross GL. Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2009;266:787–93. Epub 2009 Mar 21.CrossRefPubMedGoogle Scholar
  44. 44.
    Nason RW, Torchia MG, Morales CM, et al. Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: A solution for sentinel lymph node biopsy in mucosal head and neck cancer. Head Neck 2005;27:333–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Ross GL, Shoaib T, Soutar DS, et al. The first international conference on sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002;9:406–10.CrossRefPubMedGoogle Scholar
  46. 46.
    Stoeckli SJ, Pfaltz M, Ross GL, et al. The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 2005;12:919–24. Epub 2005 Sep 19.CrossRefPubMedGoogle Scholar
  47. 47.
    Ross GL, Soutar DS, Gordon MacDonald D, et al. Sentinel node biopsy in head and neck cancer: Preliminary results of a multicenter trial. Ann Surg Oncol 2004;11:690–6. Epub 2004 Jun 14.CrossRefPubMedGoogle Scholar
  48. 48.
    Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1–T2 oral squamous cell carcinomas: Results of a prospective multi-institutional trial. J Clin Oncol 2010;28:1395–1400. Epub 2010 Feb 8.PubMedCentralCrossRefPubMedGoogle Scholar
  49. 49.
    Shoaib T, Soutar DS, Prosser JE, et al. A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 1999;21:728–33.CrossRefPubMedGoogle Scholar
  50. 50.
    Pitman KT, Johnson JT, Brown ML, et al. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope 2002;112:2101–13.CrossRefPubMedGoogle Scholar
  51. 51.
    Torchia MG, Nason R, Danzinger R, et al. Interstitial MR lymphangiography for the detection of sentinel lymph nodes. J Surg Oncol 2001;78:151–7.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2012

Authors and Affiliations

  1. 1.Department of Surgery, Faculty of MedicineUniversity of ManitobaWinnipegCanada
  2. 2.Head and Neck Surgical Oncology, CancerCare Manitoba, Department of SurgeryUniversity of ManitobaWinnipegCanada

Personalised recommendations